Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
30)/b12-11+/t18-
is a pharmaceutical drug substance that is indicated for treatment of chronic myeloid leukemia (CML)
and fixed combination netarsudil-latanoprost
5H-indeno[1
with an IC₅₀ in the nanomolar range
Dolutegravir - CAS# 1051375-16-6 Catalog No.:M11383-2 30)/b12-11+/t18-Dolutegravir, also known as GSK1349572, is a potent inhibitor of HIV integrase with an IC50 value of 2. 7 nM for HIV 1 integrase catalyzed strand transfer in vitro. 1 It inhibits HIV 1 viral replication (EC50 = 0. 51 nM) in peripheral blood mononuclear cells (PBMCs). Dolutegravir (DTG) is an antiretroviral medication used, together with other medication, to treat HIV AIDS. It may also be used, as part of post exposure prophylaxis, to prevent HIV
US$ 12.00
US$ 38.00
US$ 172.88
US$ 11.00
US$ 22.00